MHC class II-restricted antigen processing depends upon a complex series of events involving: a) the assembly of class II alphabeta-invariant chain nonamers in the endoplasmic reticulum (ER); b) their transport through the Golgi apparatus and delivery into the endosomal/lysosomal system; c) partial disassembly of the complexes by invariant chain proteolysis; d) loading of peptides derived from internalized proteins into released alphabeta dimers; e) delivery of the peptide-loaded alphabeta dimers tot he plasma membrane. This proposal seeks to further define the role in assembly of calnexin and other chaperones and to examine the role of calnexin and the p35 and p43 forms of the invariant chain in ER retention of alphabeta-invariant chain complexes. It also seeks to determine whether the p41/p43 forms of the invariant chain play a particular role in assembly by virtue of their ability to interact with free class II alpha- and beta- subunits and/or whether this property is important in the endosomal disassembly of alphabeta-invariant chain complexes and the peptide loading process. The effects of coexpression with p43/p41 versus p35/p33 on the spectrum of peptides associated with class II molecules will also be compared. To further understanding of class II processing mechanisms in professional antigen presenting cells, studies will be initiated of class II-positive human macrophage lines, one, Mono Mac 6, which is naturally class II positive, and others which will be rendered class II-positive by transfection with the class II transactivating gene (CIITA). Class II assembly and transport, the interaction of class Ii molecules with the phagocytic and endocytic systems of the macrophage, alphabetaI disassembly and peptide loading, and antigen presentation will be examined in these model systems. The HLA-DM genes involved in antigen processing were identified by change isolation of mutants in cells hemizygous for the HLA complex, which facilitated their identification. Important genes unlinked to the MHC are difficult to identify by mutagenesis because of homozygosity and the requirement for double mutants. CIITA induces the expression of all class II structural genes, the invariant chain gene and the HLA-DM genes. It is hypothesized that other genes important for class II- restricted antigen processing are likely to be co-regulated by CIITA, and it is proposed to isolate and identify such genes by subractive hybridization using cDNA from class II-negative cells and transfectants of these cells expressing CIITA. Overall, this proposal is designed to further our understanding of the critical intracellular mechanisms involved in antigen processing.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI023081-16
Application #
6149752
Study Section
Immunobiology Study Section (IMB)
Program Officer
Deckhut Augustine, Alison M
Project Start
1986-01-01
Project End
2001-01-31
Budget Start
2000-02-01
Budget End
2001-01-31
Support Year
16
Fiscal Year
2000
Total Cost
$242,844
Indirect Cost
Name
Yale University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Roche, Paul A; Cresswell, Peter (2011) Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA. 1991. 88: 3150-3154. J Immunol 187:1076-80
Wearsch, Pamela A; Cresswell, Peter (2008) The quality control of MHC class I peptide loading. Curr Opin Cell Biol 20:624-31
Sinnathamby, Gomathinayagam; Maric, Maja; Cresswell, Peter et al. (2004) Differential requirements for endosomal reduction in the presentation of two H2-E(d)-restricted epitopes from influenza hemagglutinin. J Immunol 172:6607-14
Ackerman, Anne L; Cresswell, Peter (2003) Regulation of MHC class I transport in human dendritic cells and the dendritic-like cell line KG-1. J Immunol 170:4178-88
Phan, Uyen T; Maric, Maja; Cresswell, Peter (2002) Disulfide reduction in major histocompatibility complex class II-restricted antigen processing by interferon-gamma-inducible lysosomal thiol reductase. Methods Enzymol 348:43-8
Kang, Suk-Jo; Cresswell, Peter (2002) Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J Biol Chem 277:44838-44
Phan, Uyen T; Lackman, Rebecca L; Cresswell, Peter (2002) Role of the C-terminal propeptide in the activity and maturation of gamma -interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A 99:12298-303
Maric, M; Arunachalam, B; Phan, U T et al. (2001) Defective antigen processing in GILT-free mice. Science 294:1361-5
Cannon, K S; Cresswell, P (2001) Quality control of transmembrane domain assembly in the tetraspanin CD82. EMBO J 20:2443-53
Phan, U T; Maric, M; Dick, T P et al. (2001) Multiple species express thiol oxidoreductases related to GILT. Immunogenetics 53:342-6

Showing the most recent 10 out of 42 publications